FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Sensor, Glucose, Invasive
PMA: P120005
·
Supplement: S088
·
Decision Jan 20, 2022
Classifications
1
FEI Numbers
23
Registration Numbers
23
Basic Information
- Device Name
- Sensor, Glucose, Invasive
- Trade Name
- Dexcom G5 Mobile Continuous Glucose Monitoring System
- PMA Number
- P120005
- Supplement Number
- S088
- Device Class
- FDA Class 3
- Product Code
- MDS
- Generic Name
- Sensor, glucose, invasive
- Medical Specialty
- Unknown
- Advisory Committee
- Clinical Chemistry
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- January 20, 2022
- Date Received
- April 19, 2021
- Supplement Type
- Normal 180 Day Track No User Fee
- Supplement Reason
- Postapproval Study Protocol
- Expedited Review
- N
Advisory Committee Statement
Approval of continuous pediatric enrollment for the post-approval study (PAS) protocol.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MDS | Sensor, Glucose, Invasive | FDA class 3 | Unknown |